Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc.（INFIQ）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · INFIQ · 截至 Jun 8, 2026
关键指标
探索 Infinity Pharmaceuticals, Inc. 数据
infiq stock data · financials财务快照
完整财报分析师评级与目标价
完整预测合计: 14 · 买入占比: 35.7%
竞争对手与同行
infiq competitorsINFIQ
AFIB
ARDS
BTAX
EVLO
HSTC股票表现
完整历史关于 Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company, focuses on developing novel medicines for people with cancer. The company's product candidate, including eganelisib (IPI-549…
what is infinity pharmaceuticals, inc. · infiq stock overview · infinity pharmaceuticals, inc. company profile · who is infinity pharmaceuticals, inc. ceo · infiq OTC · infinity pharmaceuticals, inc. headquarters · infinity pharmaceuticals, inc. business segments
关于股票概览与关键数据
Infinity Pharmaceuticals, Inc.（INFIQ）是 Biotechnology 行业的 Healthcare 类公司，于 Jul 27, 2000 在 OTC 上市。截至最近交易日，INFIQ 股价为 $0.00，市值约为 $9,076。过去12个月累计回报 +9900.00%，年初至今回报 +0.00%。
根据 14 位华尔街分析师，Infinity Pharmaceuticals, Inc. 股票共识评级为Hold，12个月平均目标价为 $—。2022 财年 Infinity Pharmaceuticals, Inc. 营收 $2.6M，净利润 -$44.4M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。
常见问题
截至最近一个交易日，Infinity Pharmaceuticals, Inc.（INFIQ）股价为 $0.00，在 OTC 上市，52周区间为 $0.00 – $0.00。